[
  {
    "ts": null,
    "headline": "Why Novartis Remains A 'Buy' After Beating Expectations Again",
    "summary": "Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read why I maintain my Buy rating on NVS.",
    "url": "https://finnhub.io/api/news?id=b49f962f627f1665d614d75198e399ec2db6f521a9c90fdc497f9d42746bdc43",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740650974,
      "headline": "Why Novartis Remains A 'Buy' After Beating Expectations Again",
      "id": 132900099,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1795327693/image_1795327693.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read why I maintain my Buy rating on NVS.",
      "url": "https://finnhub.io/api/news?id=b49f962f627f1665d614d75198e399ec2db6f521a9c90fdc497f9d42746bdc43"
    }
  }
]